Variable . | T1D . | T2D . | P Valuea . | ||
---|---|---|---|---|---|
Change in M-Value, % (95% CI) . | P Value . | Change in M-Value, % (95% CI) . | P Value . | ||
Ageb | −0.4 (−1.3 to 0.5) | 0.378 | 0.3 (−0.6 to 1.2) | 0.495 | 0.269 |
Female sexc | −5.7 (−21.4 to 13.2) | 0.533 | −7.2 (−22.4 to 10.9) | 0.413 | 0.898 |
Weight | −0.3 (−1.8 to 1.1) | 0.646 | 0.3 (−0.9 to 1.6) | 0.589 | 0.462 |
BMIb | −5.6 (−7.6 to −3.6) | < 0.001d | −4.6 (−6.6 to −2.6) | < 0.001d | 0.470 |
Waist circumference | −1.1 (−2.7 to 0.4) | 0.159 | −0.9 (−2.4 to 0.7) | 0.280 | 0.870 |
WHRb | −67.4 (−93.1 to 55.3) | 0.164 | −79.0 (−96.6 to 32.3) | 0.102 | 0.674 |
Diabetes durationb | −0.1 (−0.1 to 0.0) | 0.304 | 0.0 (0.0 to 0.1) | 0.269 | 0.131 |
Fasting glucoseb | −4.8 (−7.8 to −1.6) | 0.005d | −7.0 (−12.0 to −0.17) | 0.013d | 0.507 |
HbA1c, mmol/molb | −0.57 (−1.11 to −0.02) | 0.047d | −0.75 (−1.66 to 0.16) | 0.113 | 0.746 |
HbA1c, %b | −6.0 (−11.5 to −0.2) | 0.047d | −7.9 (−16.5 to 1.8) | 0.113 | 0.746 |
Triglyceridese,f | −2.2 (−3.8 to −0.5) | 0.012d | −1.7 (−2.9 to −0.4) | 0.011d | 0.633 |
HDLb,f | 16.7 (−7.4 to 47.2) | 0.196 | 31.0 (−1.8 to 74.7) | 0.071 | 0.475 |
LDLb,f | 4.7 (−5.4 to 15.9) | 0.377 | −3.9 (−12.0 to 5.0) | 0.382 | 0.216 |
ASTe | 1.8 (−0.9 to 4.6) | 0.196 | −0.3 (−2.4 to 1.8) | 0.765 | 0.224 |
ALTe | 0.4 (−1.6 to 2.4) | 0.703 | −1.0 (−2.4 to 0.4) | 0.161 | 0.275 |
GGTe | 0.01 (−1.5 to 1.5) | 0.989 | −1.5 (−2.8 to −0.1) | 0.047d | 0.176 |
CRPe | −0.7 (−1.5 to 0.1) | 0.078 | −0.7 (−1.6 to 0.1) | 0.105 | 0.982 |
IL-6e | −0.1 (−1.3 to 1.1) | 0.881 | −0.5 (−1.6 to 0.6) | 0.368 | 0.673 |
Total adiponectine | 0.5 (−2.1 to 3.2) | 0.881 | 2.9 (0.6 to 5.1) | 0.015d | 0.171 |
HMW adiponectine | 0.6 (−1.0 to 2.3) | 0.472 | 1.8 (0.1 to 3.4) | 0.039d | 0.240 |
HMW/total adiponectin ratioe | 1.7 (−1.6 to 5.1) | 0.318 | 1.7 (−2.5 to 6.0) | 0.447 | 0.771 |
Variable . | T1D . | T2D . | P Valuea . | ||
---|---|---|---|---|---|
Change in M-Value, % (95% CI) . | P Value . | Change in M-Value, % (95% CI) . | P Value . | ||
Ageb | −0.4 (−1.3 to 0.5) | 0.378 | 0.3 (−0.6 to 1.2) | 0.495 | 0.269 |
Female sexc | −5.7 (−21.4 to 13.2) | 0.533 | −7.2 (−22.4 to 10.9) | 0.413 | 0.898 |
Weight | −0.3 (−1.8 to 1.1) | 0.646 | 0.3 (−0.9 to 1.6) | 0.589 | 0.462 |
BMIb | −5.6 (−7.6 to −3.6) | < 0.001d | −4.6 (−6.6 to −2.6) | < 0.001d | 0.470 |
Waist circumference | −1.1 (−2.7 to 0.4) | 0.159 | −0.9 (−2.4 to 0.7) | 0.280 | 0.870 |
WHRb | −67.4 (−93.1 to 55.3) | 0.164 | −79.0 (−96.6 to 32.3) | 0.102 | 0.674 |
Diabetes durationb | −0.1 (−0.1 to 0.0) | 0.304 | 0.0 (0.0 to 0.1) | 0.269 | 0.131 |
Fasting glucoseb | −4.8 (−7.8 to −1.6) | 0.005d | −7.0 (−12.0 to −0.17) | 0.013d | 0.507 |
HbA1c, mmol/molb | −0.57 (−1.11 to −0.02) | 0.047d | −0.75 (−1.66 to 0.16) | 0.113 | 0.746 |
HbA1c, %b | −6.0 (−11.5 to −0.2) | 0.047d | −7.9 (−16.5 to 1.8) | 0.113 | 0.746 |
Triglyceridese,f | −2.2 (−3.8 to −0.5) | 0.012d | −1.7 (−2.9 to −0.4) | 0.011d | 0.633 |
HDLb,f | 16.7 (−7.4 to 47.2) | 0.196 | 31.0 (−1.8 to 74.7) | 0.071 | 0.475 |
LDLb,f | 4.7 (−5.4 to 15.9) | 0.377 | −3.9 (−12.0 to 5.0) | 0.382 | 0.216 |
ASTe | 1.8 (−0.9 to 4.6) | 0.196 | −0.3 (−2.4 to 1.8) | 0.765 | 0.224 |
ALTe | 0.4 (−1.6 to 2.4) | 0.703 | −1.0 (−2.4 to 0.4) | 0.161 | 0.275 |
GGTe | 0.01 (−1.5 to 1.5) | 0.989 | −1.5 (−2.8 to −0.1) | 0.047d | 0.176 |
CRPe | −0.7 (−1.5 to 0.1) | 0.078 | −0.7 (−1.6 to 0.1) | 0.105 | 0.982 |
IL-6e | −0.1 (−1.3 to 1.1) | 0.881 | −0.5 (−1.6 to 0.6) | 0.368 | 0.673 |
Total adiponectine | 0.5 (−2.1 to 3.2) | 0.881 | 2.9 (0.6 to 5.1) | 0.015d | 0.171 |
HMW adiponectine | 0.6 (−1.0 to 2.3) | 0.472 | 1.8 (0.1 to 3.4) | 0.039d | 0.240 |
HMW/total adiponectin ratioe | 1.7 (−1.6 to 5.1) | 0.318 | 1.7 (−2.5 to 6.0) | 0.447 | 0.771 |
Multiple linear regression models adjusted for age, sex, and BMI.
P value for difference of relative change in M-value between T1D and T2D.
Relative change in M-value (%) for a one-unit increase of an independent variable. cRelative change in M-value (%) compared with men.
Statistically significant.
Relative change in M-value (%) for a 10%-change in the independent variable.
Also adjusted for lipid-lowering agents.
Variable . | T1D . | T2D . | P Valuea . | ||
---|---|---|---|---|---|
Change in M-Value, % (95% CI) . | P Value . | Change in M-Value, % (95% CI) . | P Value . | ||
Ageb | −0.4 (−1.3 to 0.5) | 0.378 | 0.3 (−0.6 to 1.2) | 0.495 | 0.269 |
Female sexc | −5.7 (−21.4 to 13.2) | 0.533 | −7.2 (−22.4 to 10.9) | 0.413 | 0.898 |
Weight | −0.3 (−1.8 to 1.1) | 0.646 | 0.3 (−0.9 to 1.6) | 0.589 | 0.462 |
BMIb | −5.6 (−7.6 to −3.6) | < 0.001d | −4.6 (−6.6 to −2.6) | < 0.001d | 0.470 |
Waist circumference | −1.1 (−2.7 to 0.4) | 0.159 | −0.9 (−2.4 to 0.7) | 0.280 | 0.870 |
WHRb | −67.4 (−93.1 to 55.3) | 0.164 | −79.0 (−96.6 to 32.3) | 0.102 | 0.674 |
Diabetes durationb | −0.1 (−0.1 to 0.0) | 0.304 | 0.0 (0.0 to 0.1) | 0.269 | 0.131 |
Fasting glucoseb | −4.8 (−7.8 to −1.6) | 0.005d | −7.0 (−12.0 to −0.17) | 0.013d | 0.507 |
HbA1c, mmol/molb | −0.57 (−1.11 to −0.02) | 0.047d | −0.75 (−1.66 to 0.16) | 0.113 | 0.746 |
HbA1c, %b | −6.0 (−11.5 to −0.2) | 0.047d | −7.9 (−16.5 to 1.8) | 0.113 | 0.746 |
Triglyceridese,f | −2.2 (−3.8 to −0.5) | 0.012d | −1.7 (−2.9 to −0.4) | 0.011d | 0.633 |
HDLb,f | 16.7 (−7.4 to 47.2) | 0.196 | 31.0 (−1.8 to 74.7) | 0.071 | 0.475 |
LDLb,f | 4.7 (−5.4 to 15.9) | 0.377 | −3.9 (−12.0 to 5.0) | 0.382 | 0.216 |
ASTe | 1.8 (−0.9 to 4.6) | 0.196 | −0.3 (−2.4 to 1.8) | 0.765 | 0.224 |
ALTe | 0.4 (−1.6 to 2.4) | 0.703 | −1.0 (−2.4 to 0.4) | 0.161 | 0.275 |
GGTe | 0.01 (−1.5 to 1.5) | 0.989 | −1.5 (−2.8 to −0.1) | 0.047d | 0.176 |
CRPe | −0.7 (−1.5 to 0.1) | 0.078 | −0.7 (−1.6 to 0.1) | 0.105 | 0.982 |
IL-6e | −0.1 (−1.3 to 1.1) | 0.881 | −0.5 (−1.6 to 0.6) | 0.368 | 0.673 |
Total adiponectine | 0.5 (−2.1 to 3.2) | 0.881 | 2.9 (0.6 to 5.1) | 0.015d | 0.171 |
HMW adiponectine | 0.6 (−1.0 to 2.3) | 0.472 | 1.8 (0.1 to 3.4) | 0.039d | 0.240 |
HMW/total adiponectin ratioe | 1.7 (−1.6 to 5.1) | 0.318 | 1.7 (−2.5 to 6.0) | 0.447 | 0.771 |
Variable . | T1D . | T2D . | P Valuea . | ||
---|---|---|---|---|---|
Change in M-Value, % (95% CI) . | P Value . | Change in M-Value, % (95% CI) . | P Value . | ||
Ageb | −0.4 (−1.3 to 0.5) | 0.378 | 0.3 (−0.6 to 1.2) | 0.495 | 0.269 |
Female sexc | −5.7 (−21.4 to 13.2) | 0.533 | −7.2 (−22.4 to 10.9) | 0.413 | 0.898 |
Weight | −0.3 (−1.8 to 1.1) | 0.646 | 0.3 (−0.9 to 1.6) | 0.589 | 0.462 |
BMIb | −5.6 (−7.6 to −3.6) | < 0.001d | −4.6 (−6.6 to −2.6) | < 0.001d | 0.470 |
Waist circumference | −1.1 (−2.7 to 0.4) | 0.159 | −0.9 (−2.4 to 0.7) | 0.280 | 0.870 |
WHRb | −67.4 (−93.1 to 55.3) | 0.164 | −79.0 (−96.6 to 32.3) | 0.102 | 0.674 |
Diabetes durationb | −0.1 (−0.1 to 0.0) | 0.304 | 0.0 (0.0 to 0.1) | 0.269 | 0.131 |
Fasting glucoseb | −4.8 (−7.8 to −1.6) | 0.005d | −7.0 (−12.0 to −0.17) | 0.013d | 0.507 |
HbA1c, mmol/molb | −0.57 (−1.11 to −0.02) | 0.047d | −0.75 (−1.66 to 0.16) | 0.113 | 0.746 |
HbA1c, %b | −6.0 (−11.5 to −0.2) | 0.047d | −7.9 (−16.5 to 1.8) | 0.113 | 0.746 |
Triglyceridese,f | −2.2 (−3.8 to −0.5) | 0.012d | −1.7 (−2.9 to −0.4) | 0.011d | 0.633 |
HDLb,f | 16.7 (−7.4 to 47.2) | 0.196 | 31.0 (−1.8 to 74.7) | 0.071 | 0.475 |
LDLb,f | 4.7 (−5.4 to 15.9) | 0.377 | −3.9 (−12.0 to 5.0) | 0.382 | 0.216 |
ASTe | 1.8 (−0.9 to 4.6) | 0.196 | −0.3 (−2.4 to 1.8) | 0.765 | 0.224 |
ALTe | 0.4 (−1.6 to 2.4) | 0.703 | −1.0 (−2.4 to 0.4) | 0.161 | 0.275 |
GGTe | 0.01 (−1.5 to 1.5) | 0.989 | −1.5 (−2.8 to −0.1) | 0.047d | 0.176 |
CRPe | −0.7 (−1.5 to 0.1) | 0.078 | −0.7 (−1.6 to 0.1) | 0.105 | 0.982 |
IL-6e | −0.1 (−1.3 to 1.1) | 0.881 | −0.5 (−1.6 to 0.6) | 0.368 | 0.673 |
Total adiponectine | 0.5 (−2.1 to 3.2) | 0.881 | 2.9 (0.6 to 5.1) | 0.015d | 0.171 |
HMW adiponectine | 0.6 (−1.0 to 2.3) | 0.472 | 1.8 (0.1 to 3.4) | 0.039d | 0.240 |
HMW/total adiponectin ratioe | 1.7 (−1.6 to 5.1) | 0.318 | 1.7 (−2.5 to 6.0) | 0.447 | 0.771 |
Multiple linear regression models adjusted for age, sex, and BMI.
P value for difference of relative change in M-value between T1D and T2D.
Relative change in M-value (%) for a one-unit increase of an independent variable. cRelative change in M-value (%) compared with men.
Statistically significant.
Relative change in M-value (%) for a 10%-change in the independent variable.
Also adjusted for lipid-lowering agents.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.